Heterozygote detection in angiokeratoma corporis diffusum (Anderson-Fabry disease). Studies on plasma, leucocytes, and hair follicles.

Heterozygote detection for angiokeratoma corporis diffusum (Anderson-Fabry disease, ACD), an X-linked disorder of glycosphingolipid metabolism was examined using alpha-galactosidase activity, an alpha-galactosidase/beta-galactosidase activity ratios (alpha/beta ratio) in leucocytes, plasma, and hair follicles; For leucocytes, 22 obligate heterozygotes, 25 suspected heterozygotes, and 47 control subjects were studied, while for plasma, the groups were 17 obligate heterozygotes and 35 controls. The alpha/beta ratio in plasma and leucocytes was clearly a better discriminator between obligate heterozygotes and controls than alpha-galactosidase activity alone, but still failed to detect 3 obligates with leucocytes and 2 with plasma. Discrimination was not improved by joint use of plasma and leucocyte alpha/beta ratios, but was improved by measurement of hair-follicle alpha/beta ratios. The interdecile range of log (alpha-galactosidase/beta-galactosidase activity) in 20 hair follicles from each of 4 obligate and 7 suspected heterozygotes was clearly different from 11 control subjects. Accordingly, for rapid screening for carriers of ACD, we recommend use of leucocyte or plasma alpha/beta ratios which should detect greater than 85% of heterozygotes. When results are equivocal, and ancillary information suggests heterozygous status, the more time-consuming measurement of hair-follicle alpha/beta ratios is a useful additional test.

[1]  J. Embil,et al.  A New Variant of Sandhoff's Disease , 1974, Pediatric Research.

[2]  M. Cotton,et al.  HETEROZYGOTE DETECTION IN FABRY'S DISEASE , 1974, Pediatric Research.

[3]  R. Desnick,et al.  Letter: Diagnosis of Fabry's disease by tear alpha-galactosidase A. , 1974, The New England journal of medicine.

[4]  C. Sweeley,et al.  Galactosyl(α1→4)galactosylceramide: Galactosyl hydrolase activity in normal and Fabry plasma , 1973 .

[5]  J. Convit,et al.  Fabry's disease: normal α‐galactosidase activity and urinary‐sediment glycosphingolipid levels in two obligate heterozygotes , 1973, The British journal of dermatology.

[6]  C. Sweeley,et al.  Preparation and properties of an affinity column adsorbent for differentiation of multiple forms of -galactosidase activity. , 1973, The Journal of biological chemistry.

[7]  U. Francke,et al.  Detection of heterozygous carriers of the Lesch-Nyhan syndrome by electrophoresis of hair root lysates. , 1973, The Journal of pediatrics.

[8]  R. Desnick,et al.  Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. , 1973, The Journal of laboratory and clinical medicine.

[9]  K. Grzeschik,et al.  X-Linkage of Human α-Galactosidase , 1972 .

[10]  M. W. Spence,et al.  Attempted detection of heterozygotes for maple‐syrup‐urine disease , 1972, Clinical genetics.

[11]  C. Sweeley,et al.  Substrate specificity of ceramide trihexosidase , 1972, FEBS letters.

[12]  J. Tager,et al.  Detection of Fabry hemizygotes and heterozygotes by measurement of -galactosidase in urine. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[13]  L. Tennant,et al.  Fabry's disease: evidence for a physically altered -galactosidase. , 1972, American journal of human genetics.

[14]  E. Beutler,et al.  Biochemical and electrophoretic studies of -galactosidase in normal man, in patients with Fabry's disease, and in Equidae. , 1972, American journal of human genetics.

[15]  J. Dancis,et al.  Detection of heterozygote in Lesch-Nyhan disease by hair-root analysis. , 1972, The New England journal of medicine.

[16]  S. Gartler,et al.  Glucose‐6‐phosphate dehydrogenase mosaicism: utilization in the study of hair follicle variegation , 1971 .

[17]  J. Goldstein,et al.  Lesch-Nyhan Syndrome: Rapid Detection of Heterozygotes by Use of Hair Follicles , 1971, Science.

[18]  P. Gregoire,et al.  [Urinary glycolipids in Fabry's disease]. , 1971, Clinica chimica acta; international journal of clinical chemistry.

[19]  B. Migeon,et al.  Genetic Inactivation of the α-Galactosidase Locus in Carriers of Fabry's Disease , 1970, Science.

[20]  C. Sweeley,et al.  Galactosylgalactosylglucosylceramide: Galactosyl hydrolase in normal human plasma and its absence in patients with fabry's disease , 1970, FEBS letters.

[21]  J. Kint Fabry's Disease: Alpha-Galactosidase Deficiency , 1970, Science.

[22]  J. O'brien,et al.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay. , 1970, The New England journal of medicine.

[23]  S. Gartler,et al.  Glucose‐6 phosphate dehydrogenase mosaicism: utilization as a tracer in the study of the development of hair root cells * , 1969, Annals of human genetics.

[24]  B. Migeon,et al.  X-Linked Hypoxanthine-Guanine Phosphoribosyl Transferase Deficiency: Heterozygote Has Two Clonal Populations , 1968, Science.

[25]  A. Bearn,et al.  HURLER'S SYNDROME: A GENETIC STUDY OF CLONES IN CELL CULTURE WITH PARTICULAR REFERENCE TO THE LYON HYPOTHESIS , 1967, The Journal of experimental medicine.

[26]  R. Brady,et al.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. , 1967, The New England journal of medicine.

[27]  C. Kattamis Glucose‐6‐Phosphate Dehydrogenase Deficiency in Female Heterozygoses and the X‐Inactivation Hypothesis , 1967, Acta paediatrica Scandinavica.

[28]  B. Childs,et al.  DEMONSTRATION OF TWO POPULATIONS OF CELLS IN THE HUMAN FEMALE HETEROZYGOUS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE VARIANTS. , 1963, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Lyon Gene Action in the X-chromosome of the Mouse (Mus musculus L.) , 1961, Nature.

[30]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.